Geron - 8 Year Dividend History | GERN

Historical dividend payout and yield for Geron (GERN) since 2016. The current TTM dividend payout for Geron (GERN) as of May 24, 2024 is $0.00. The current dividend yield for Geron as of May 24, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.064B $0.000B
Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic malignancies. The Company currently is conducting two Phase 3 clinical trials: IMerge in lower risk myelodysplastic syndromes and IMpactMF in refractory myelofibrosis.
Stock Name Country Market Cap PE Ratio